Sernova Corp (SVA) – Strategy, SWOT and Corporate Finance Report

Sernova Corp (SVA) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like environment for the long-term survival and function of insulin producing islets for the treatment of diabetes. Sernova uses proprietary local immune protection technologies that protect therapeutic cells within the Cell Pouch from the attack of immune system. Its major pipeline products include human donor islets, microencapsulated islets; microencapsulated stem cell derived cells; corrected patient cells; allograft immune protected cells; and autograft thyroid cells. The company’s product portfolio addresses metabolic diseases such as insulin dependent diabetes, thyroid problems, and blood disorders such as hemophilia A and other diseases. Sernova is headquartered in London, Ontario, Canada.

Scope

• Detailed information on Sernova Corp required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Sernova Corp in the form of a SWOT analysis

• An in-depth view of the business model of Sernova Corp including a breakdown and examination of key business segments

• News about Sernova Corp, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Sernova Corp and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Sernova Corp as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Sernova Corps business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Diamyd Medical AB

ConjuChem LLC

Generex Biotechnology Corp

Alnara Pharmaceuticals Inc

AstraZeneca Plc

Semma Therapeutics Inc

Sigilon Therapeutics Inc

Diamyd Medical AB

Alnara Pharmaceuticals Inc

AstraZeneca Plc

ConjuChem LLC

Generex Biotechnology Corp

Sigilon Therapeutics Inc

Semma Therapeutics Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Sernova Corp - Key Facts

Sernova Corp - Key Employees

Sernova Corp - Key Employee Biographies

Sernova Corp - Major Products and Services

Sernova Corp - History

Sernova Corp - Company Statement

Sernova Corp - Locations And Subsidiaries

Head Office

Section 2 – Company Analysis

Company Overview

Sernova Corp - Business Description

R&D Overview

Sernova Corp - Corporate Strategy

Sernova Corp - SWOT Analysis

SWOT Analysis - Overview

Sernova Corp - Strengths

Sernova Corp - Weaknesses

Sernova Corp - Opportunities

Sernova Corp - Threats

Sernova Corp - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Sernova Corp, Medical Equipment, Deals By Year, 2016 to YTD 2022

Sernova Corp, Medical Equipment, Deals By Type, 2016 to YTD 2022

Sernova Corp, Recent Deals Summary

Section 5 – Company’s Recent Developments

Dec 06, 2022: Sernova Corp. Announces CEO Succession Plan and Expanded Management Team

Sep 07, 2022: Sernova announces the appointment of Daniel Mahony, Ph.D. to its Board of Directors

Jun 15, 2022: Sernova to participate in the Truist Securities Cell Therapy Symposium, Symposia-cel in June

May 18, 2022: Sernova and Evotec collaborate to develop cell therapy for diabetes

May 05, 2022: Sernova to participate in Multiple U.S. Healthcare Investor Conferences

Dec 14, 2021: Sernova appoints Christopher Barnes as Vice President, investor relations & grants options/DSUs

Dec 02, 2021: Sernova announces appointment of executive chair to complement its management team

Sep 29, 2021: Sernova engages New York-Based LifeSci Advisors as US investor relations partner

Jun 30, 2021: Industry veteran Frank Shannon joins Sernova as VP Clinical Development and Regulatory Affairs

May 04, 2021: Sernova announces the nomination of seasoned pharma executive Dr. Mohammad Azab to its board of directors

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Sernova Corp, Key Facts

Sernova Corp, Key Employees

Sernova Corp, Key Employee Biographies

Sernova Corp, Major Products and Services

Sernova Corp, History

Sernova Corp, Key Competitors

Sernova Corp, Ratios based on current share price

Sernova Corp, Annual Ratios

Sernova Corp, Annual Ratios (Cont…1)

Sernova Corp, Interim Ratios

Sernova Corp, Medical Equipment, Deals By Year, 2016 to YTD 2022

Sernova Corp, Medical Equipment, Deals By Type, 2016 to YTD 2022

Sernova Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Sernova Corp, Performance Chart (2017 – 2021)

Sernova Corp, Ratio Charts

Sernova Corp, Medical Equipment, Deals By Year, 2016 to YTD 2022

Sernova Corp, Medical Equipment, Deals by Type, 2016 to YTD 2022

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports